Next Article in Journal
Endocrine and Neuroendocrine Tumors: A Special Issue
Next Article in Special Issue
The Efficacy and Safety of Immune Checkpoint Inhibitor and Tyrosine Kinase Inhibitor Combination Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Real-World Cohort Study
Previous Article in Journal
Risk Factors Associated with Pancreatic Cancer in the UK Biobank Cohort
Previous Article in Special Issue
Role of the Systemic Immune-Inflammation Index in Patients with Metastatic Renal Cell Carcinoma Treated with First-Line Ipilimumab plus Nivolumab
 
 
Article

Article Versions Notes

Cancers 2022, 14(20), 4992; https://doi.org/10.3390/cancers14204992
Action Date Notes Link
article xml file uploaded 12 October 2022 10:57 CEST Original file -
article xml uploaded. 12 October 2022 10:57 CEST Update -
article pdf uploaded. 12 October 2022 10:57 CEST Version of Record https://www.mdpi.com/2072-6694/14/20/4992/pdf-vor
article supplementary file uploaded. 12 October 2022 10:57 CEST - https://www.mdpi.com/2072-6694/14/20/4992#supplementary
article html file updated 12 October 2022 10:58 CEST Original file -
article xml file uploaded 13 October 2022 07:27 CEST Update -
article xml uploaded. 13 October 2022 07:27 CEST Update https://www.mdpi.com/2072-6694/14/20/4992/xml
article pdf uploaded. 13 October 2022 07:27 CEST Updated version of record https://www.mdpi.com/2072-6694/14/20/4992/pdf
article html file updated 13 October 2022 07:29 CEST Update -
article html file updated 28 February 2023 17:40 CET Update -
article html file updated 1 March 2023 21:00 CET Update https://www.mdpi.com/2072-6694/14/20/4992/html
Back to TopTop